FindMyKOL
Clinical trialNCT05521997Not, yet, recruitingPhase 2Interventional

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

SponsorWashington University School of MedicineEnrollment42Advanced Cervical CarcinomaCancer of the CervixCervical CancerCervix Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Advanced cervical cancer patients treated with standard of care (SOC) chemoradiation plus glutaminase inhibition with telaglenastat (CB-839) will have increased progression-free survival (PFS) compared to historical rates for patients receiving SOC chemoradiation alone.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Julie K Schwarz, M.D., Ph.D.

    Washington University School of Medicine

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Andrea Hagemann, M.D., MSCICarolyn McCourt, M.D.David DeNardo, Ph.D.David Mutch, M.D.Dineo Khabele, M.D.Esther Lu, Ph.D.Gary Patti, Ph.D.Julie K Schwarz, M.D., Ph.D.L. Stewart Massad, M.D.Li Ding, Ph.D.Lindsay Kuroki, M.D.Maggie Mullen, M.S.Matthew Powell, M.D.Premal Thaker, M.D.Stephanie Markovina, M.D., Ph.D.

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cisplatin →Telaglenastat
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2026
Primary completion
7 Oct 2032
Completion
7 Oct 2032
Last update posted
13 Mar 2026
Registered enrollment
42
Registry id
NCT05521997

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.